Valuation: Abbott Laboratories

Market Cap 17TCr 15TCr 14TCr 13TCr 24TCr 16,58800Cr 25TCr 1,66000Cr 65TCr 8,10000Cr 65TCr 63TCr 27,96600Cr P/E 2026 *
26.1x
P/E 2027 * 21.4x
Enterprise Value 19TCr 17TCr 16TCr 14TCr 27TCr 18,76400Cr 28TCr 1,87700Cr 74TCr 9,16300Cr 73TCr 72TCr 31,63400Cr EV / Sales 2026 *
3.87x
EV / Sales 2027 * 3.4x
Free-Float
86.73%
Yield 2026 *
2.58%
Yield 2027 * 2.75%
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 17TCr
+0.25%-0.23%-6.53%-3.49% 11TCr
+1.15%+2.63%+5.79%+62.08% 5.99TCr
-0.18%+4.91%-11.88%-37.89% 4.41TCr
-0.73%-0.68% - - 3.48TCr
-1.89%+1.85%-9.22%-44.45% 3.01TCr
+0.62%+3.33%+64.93%-4.73% 2.56TCr
-0.91%+1.31%-3.73%-18.94% 2.09TCr
-0.62%+1.50%-2.38%-3.99% 2.16TCr
+2.74%+1.80%-6.96%+4.13% 2TCr
Average +0.04%+2.65%+3.75%-5.91% 4.04TCr
Weighted average by Cap. +0.09%+2.50%+0.73%-0.55%

Financials

2026 *2027 *
Net sales 5.03TCr 4.4TCr 4.07TCr 3.73TCr 7.07TCr 4,85000Cr 7.19TCr 49TCr 19TCr 2,36800Cr 19TCr 18TCr 8,17700Cr 5.47TCr 4.78TCr 4.42TCr 4.06TCr 7.67TCr 5,26800Cr 7.81TCr 53TCr 21TCr 2,57200Cr 21TCr 20TCr 8,88100Cr
Net income 683.5Cr 597.45Cr 552.52Cr 507.01Cr 959.57Cr 66TCr 976.24Cr 6.59TCr 2.59TCr 32TCr 2.57TCr 2.51TCr 1,11000Cr 809.72Cr 707.78Cr 654.55Cr 600.63Cr 1.14TCr 78TCr 1.16TCr 7.81TCr 3.07TCr 38TCr 3.04TCr 2.97TCr 1,31500Cr
Net Debt 2.26TCr 1.97TCr 1.83TCr 1.68TCr 3.17TCr 2,17600Cr 3.23TCr 22TCr 8.55TCr 1,06300Cr 8.48TCr 8.29TCr 3,66900Cr 1.36TCr 1.19TCr 1.1TCr 1.01TCr 1.91TCr 1,30900Cr 1.94TCr 13TCr 5.15TCr 64TCr 5.1TCr 4.99TCr 2,20800Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-